0001179110-20-008254.txt : 20200714
0001179110-20-008254.hdr.sgml : 20200714
20200714164056
ACCESSION NUMBER: 0001179110-20-008254
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 2
CONFORMED PERIOD OF REPORT: 20200710
FILED AS OF DATE: 20200714
DATE AS OF CHANGE: 20200714
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Marshall Randall
CENTRAL INDEX KEY: 0001799325
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-36694
FILM NUMBER: 201027461
MAIL ADDRESS:
STREET 1: C/O ARTARA THERAPEUTICS, INC.
STREET 2: 1 LITTLE WEST 12TH STREET
CITY: NEW YORK
STATE: NY
ZIP: 10014
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Protara Therapeutics, Inc.
CENTRAL INDEX KEY: 0001359931
STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
IRS NUMBER: 204580525
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 1 LITTLE WEST 12TH STREET
CITY: NEW YORK
STATE: NY
ZIP: 10014
BUSINESS PHONE: 646-844-0337
MAIL ADDRESS:
STREET 1: 1 LITTLE WEST 12TH STREET
CITY: NEW YORK
STATE: NY
ZIP: 10014
FORMER COMPANY:
FORMER CONFORMED NAME: ArTara Therapeutics, Inc.
DATE OF NAME CHANGE: 20200110
FORMER COMPANY:
FORMER CONFORMED NAME: PROTEON THERAPEUTICS INC
DATE OF NAME CHANGE: 20060420
4
1
edgar.xml
FORM 4 -
X0306
4
2020-07-10
0
0001359931
Protara Therapeutics, Inc.
TARA
0001799325
Marshall Randall
6 CURVE STREET
SHERBORN
MA
01770
0
0
1
0
Common Stock
2020-07-10
4
S
0
2659
27.41
D
651361
D
Common Stock
2020-07-13
4
S
0
2145
27.13
D
649216
D
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $27.01 to $28.01, inclusive. The reporting person undertakes to provide to Protara Therapeutics, Inc., any security holder of Protara Therapeutics, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (1) and (2) to this Form 4.
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $27.00 to $27.70, inclusive.
John D. Chambliss, as Attorney-in-Fact
2020-07-14
EX-24.POA
2
ex24poa.txt
POWER OF ATTORNEY
POWER OF ATTORNEY
Know all by these presents, that the undersigned hereby constitutes and
appoints each of John D. Chambliss and Anna O. Chan, signing singly, the
undersigned's true and lawful attorney-in-fact to:
1. execute for and on behalf of the undersigned, in the undersigned's
capacity as a shareholder of Protara Therapeutics, Inc. (the "Company"),
any and all documents required by the Securities and Exchange Commission
pursuant to the Securities Exchange Act of 1934 and the rules thereunder,
including, without limitation, Section 16 Forms 3, 4 and 5 and any
amendments thereto;
2. do and perform any and all acts for and on behalf of the undersigned which
may be necessary or desirable to complete and execute any such document
filing and timely file such form with the United States Securities and
Exchange Commission and any stock exchange or similar authority; and
3. take any other action of any type whatsoever in connection with the
foregoing which, in the opinion of such attorney-in-fact, may be of
benefit to, and in the best interest of, or legally required by, the
undersigned.
The undersigned hereby grants to each such attorney-in-fact full power and
authority to do and perform any and every act and thing whatsoever requisite,
necessary, or proper to be done in the exercise of any of the rights and powers
herein granted, as fully to all intents and purposes as the undersigned might or
could do if personally present, with full power of substitution or revocation,
hereby ratifying and confirming all that such attorney-in-fact, or such
attorney-in-fact's substitute or substitutes, shall lawfully do or cause to be
done by virtue of this power of attorney and the rights and powers herein
granted. The undersigned acknowledges that the foregoing attorneys-in-fact, in
serving in such capacity at the request of the undersigned, are not assuming,
nor is the Company assuming, any of the undersigned's responsibilities to comply
with Section 16 of the Securities Exchange Act of 1934.
This Power of Attorney shall remain in full force and effect until the
undersigned is no longer required with respect to the undersigned's capacity as
a shareholder and/or holdings of and transactions in securities issued by the
Company, unless earlier revoked by the undersigned in a signed writing delivered
to the foregoing attorneys-in-fact.
IN WITNESS WHEREOF, the undersigned has caused this Power of Attorney to
be executed as of this 9th day of July, 2020.
/s/ Randall Marshall
-----------------------------------
Randall Marshall